Author

Anna England

Observed names: England, A., England, Anna

Observed institutions: Johns Hopkins University, St George's, University of London, Southampton General Hospital, Kingston Hospital NHS Trust, University of Manchester, Public Health England, University of Oxford, Kingston Hospital, University of Southampton, UK Health Security Agency, Health Protection Agency, Clinical Research Network Thames Valley and South Midlands, Makerere University, Medical Research Council, Uganda Virus Research Institute

OpenAlex ID: A5088935966

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

2021 · Xinxue Liu, Robert H Shaw, et al. · The Lancet · 478

PDF

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

2021 · Arabella S V Stuart, Robert H Shaw, et al. · The Lancet · 212

PDF

Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator

2015 · Shamez N. Ladhani, Nick J. Andrews, et al. · Clinical Infectious Diseases · 180

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

2009 · Ray Borrow, Nick Andrews, et al. · Clinical and Vaccine Immunology · 114

Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy

2016 · Alison Kent, Shamez N. Ladhani, et al. · PEDIATRICS · 33

Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom

2012 · Helen Findlow, Ray Borrow, et al. · The Pediatric Infectious Disease Journal · 31

Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age

2010 · Elizabeth Miller, Nick Andrews, et al. · Clinical and Vaccine Immunology · 28

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age

2015 · David A. Ishola, Nick Andrews, et al. · The Pediatric Infectious Disease Journal · 26

A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants

2021 · Christine Elizabeth Jones, Anna Calvert, et al. · BMC Medicine · 24

PDF

Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial

2023 · Anna Calvert, Gayatri Amirthalingam, et al. · The Lancet Microbe · 19

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule

2014 · Shamez N. Ladhani, Nick J. Andrews, et al. · Vaccine · 17

MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines

2025 · Ali Amini, Lucy C. Garner, et al. · Science Immunology · 12

Variants in the genes encoding TNF-α, IL-10, and GSTP1 influence the effect of α-tocopherol on inflammatory cell responses in healthy men

2012 · Anna England, Ana M Valdes, et al. · American Journal of Clinical Nutrition · 11

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial

2021 · Kimberly Davis, Marta Valente Pinto, et al. · The Lancet Infectious Diseases · 10

PDF

Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax®) by HIPRA

2024 · Anna England, Julia Sung, et al. · Vaccine · 2

Optimising the Timing of whooping cough Immunisation in MUMs: a randomised controlled trial investigating the timing of pertussis vaccination in pregnancy (OpTIMUM): a protocol paper

2021 · Anna Calvert, Konstantinos Karampatsas, et al. · Wellcome Open Research · 2

PDF

Estimating neutralising antibody responses against emerging SARS-CoV-2 variants utilising convalescent sera before the roll-out of XBB-lineage vaccines

2025 · Ana Atti, Anna England, et al. · Vaccine

The immunogenicity of the U.K. group B meningococcal vaccine (4CMenB) schedule against group B and C meningococcal strains: outcomes of the Sched3 randomised clinical trial.

2020 · Kim Davis, Marta Valente Pinto, et al. · The Lancet Infectious Diseases

Influence of superoxide dismutase polymorphism and overweight status on clinical outcome and oxidant production and stress in healthy middle-aged men and rheumatoid patients receiving high-dose RRR-alpha-tocopherol supplementation

2006 · Slater-Jefferies, J., England, A., et al. · ePrints Soton (University of Southampton)

Works count: 22

Citation count: 1,199

H-index: 12

I10-index: 14